ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Interventional Pain Medicine

Top Interventional Pain Medicine Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
WASHINGTON BRYAN M.D.

Interventional Pain Medicine

7,523

$2.83M

306
121 are 65+

97%
patients receiving schedule two controlled substances

Avg: 45%

0%
patients receiving schedule three controlled substances

Avg: 36%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

30%
prescriptions for brand name drugs

Avg: 23%

$376
Average prescription price

Avg: $117

NAGA THOTA MD

Interventional Pain Medicine

6,721

$965K

425
139 are 65+

84%
patients receiving schedule two controlled substances

Avg: 45%

27%
patients receiving schedule three controlled substances

Avg: 36%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 23%

$144
Average prescription price

Avg: $117

BRYAN LEE MD

Interventional Pain Medicine

5,083

$365K

568
337 are 65+

27%
patients receiving schedule two controlled substances

Avg: 45%

34%
patients receiving schedule three controlled substances

Avg: 36%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 23%

$72
Average prescription price

Avg: $117

LESTER STONEY MD

Interventional Pain Medicine

4,566

$799K

254
101 are 65+

88%
patients receiving schedule two controlled substances

Avg: 45%

30%
patients receiving schedule three controlled substances

Avg: 36%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 23%

$175
Average prescription price

Avg: $117

NAVDEEP LOOMBA MD

Interventional Pain Medicine

4,514

$281K

302
92 are 65+

53%
patients receiving schedule two controlled substances

Avg: 45%

59%
patients receiving schedule three controlled substances

Avg: 36%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

11%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $117

KYLE HERON MD

Interventional Pain Medicine

3,508

$291K

294
120 are 65+

67%
patients receiving schedule two controlled substances

Avg: 45%

56%
patients receiving schedule three controlled substances

Avg: 36%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 23%

$83
Average prescription price

Avg: $117

THOMAS KELLER M.D., M.P.H.

Interventional Pain Medicine

2,906

$848K

134
44 are 65+

82%
patients receiving schedule two controlled substances

Avg: 45%

30%
patients receiving schedule three controlled substances

Avg: 36%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 23%

$292
Average prescription price

Avg: $117

CHRISTOPHER CHARBONNET M.D.

Interventional Pain Medicine

2,827

$183K

357
253 are 65+

32%
patients receiving schedule two controlled substances

Avg: 45%

35%
patients receiving schedule three controlled substances

Avg: 36%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 23%

$65
Average prescription price

Avg: $117

HUSSEIN ABDULHADI MD

Interventional Pain Medicine

2,813

$273K

208
108 are 65+

56%
patients receiving schedule two controlled substances

Avg: 45%

37%
patients receiving schedule three controlled substances

Avg: 36%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 23%

$97
Average prescription price

Avg: $117

CHIWAI CHAN D.O.

Interventional Pain Medicine

2,687

$122K

273
114 are 65+

60%
patients receiving schedule two controlled substances

Avg: 45%

53%
patients receiving schedule three controlled substances

Avg: 36%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $117

MARC CHENG M.D.

Interventional Pain Medicine

2,449

$130K

306
188 are 65+

42%
patients receiving schedule two controlled substances

Avg: 45%

49%
patients receiving schedule three controlled substances

Avg: 36%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

12%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $117

BEN SHWACHMAN M.D.

Interventional Pain Medicine

2,446

$234K

278
157 are 65+

44%
patients receiving schedule two controlled substances

Avg: 45%

32%
patients receiving schedule three controlled substances

Avg: 36%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

28%
prescriptions for brand name drugs

Avg: 23%

$96
Average prescription price

Avg: $117

BALAJI CHARLU MD

Interventional Pain Medicine

2,365

$126K

459
416 are 65+

22%
patients receiving schedule two controlled substances

Avg: 45%

33%
patients receiving schedule three controlled substances

Avg: 36%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $117

ARUL DORAISWAMY M.D.

Interventional Pain Medicine

2,360

$179K

260
122 are 65+

52%
patients receiving schedule two controlled substances

Avg: 45%

44%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 23%

$76
Average prescription price

Avg: $117

JOHN PETRAGLIA M.D.

Interventional Pain Medicine

2,242

$309K

118
39 are 65+

68%
patients receiving schedule two controlled substances

Avg: 45%

43%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 23%

$138
Average prescription price

Avg: $117

CHRISTOPHER KAYPEKIAN M.D.

Interventional Pain Medicine

2,205

$104K

384
330 are 65+

20%
patients receiving schedule two controlled substances

Avg: 45%

47%
patients receiving schedule three controlled substances

Avg: 36%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

28%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $117

REBECCA KERR M.D.

Interventional Pain Medicine

2,018

$197K

144
89 are 65+

34%
patients receiving schedule two controlled substances

Avg: 45%

57%
patients receiving schedule three controlled substances

Avg: 36%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 23%

$98
Average prescription price

Avg: $117

DAVID WU M.D.

Interventional Pain Medicine

1,965

$149K

450
221 are 65+

68%
patients receiving schedule two controlled substances

Avg: 45%

22%
patients receiving schedule three controlled substances

Avg: 36%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 23%

$76
Average prescription price

Avg: $117

ROBERT FREY M.D.

Interventional Pain Medicine

1,931

$181K

165
71 are 65+

55%
patients receiving schedule two controlled substances

Avg: 45%

40%
patients receiving schedule three controlled substances

Avg: 36%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

14%
prescriptions for brand name drugs

Avg: 23%

$94
Average prescription price

Avg: $117

JAMES RHO M.D.

Interventional Pain Medicine

1,919

$354K

253
121 are 65+

82%
patients receiving schedule two controlled substances

Avg: 45%

27%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

45%
prescriptions for brand name drugs

Avg: 23%

$185
Average prescription price

Avg: $117

AKASH BAJAJ MD

Interventional Pain Medicine

1,891

$145K

205
111 are 65+

45%
patients receiving schedule two controlled substances

Avg: 45%

43%
patients receiving schedule three controlled substances

Avg: 36%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 23%

$76
Average prescription price

Avg: $117

PHILIP CHIOU MD

Interventional Pain Medicine

1,879

$160K

336
167 are 65+

54%
patients receiving schedule two controlled substances

Avg: 45%

38%
patients receiving schedule three controlled substances

Avg: 36%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 23%

$85
Average prescription price

Avg: $117

DAVID TEICHEIRA M.D.

Interventional Pain Medicine

1,789

$164K

104
35 are 65+

62%
patients receiving schedule two controlled substances

Avg: 45%

40%
patients receiving schedule three controlled substances

Avg: 36%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

13%
prescriptions for brand name drugs

Avg: 23%

$92
Average prescription price

Avg: $117

RICHARD GRACER MD

Interventional Pain Medicine

1,742

$217K

126
67 are 65+

44%
patients receiving schedule two controlled substances

Avg: 45%

26%
patients receiving schedule three controlled substances

Avg: 36%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 23%

$125
Average prescription price

Avg: $117

NARINDER GREWAL MD

Interventional Pain Medicine

1,552

$110K

241
70 are 65+

51%
patients receiving schedule two controlled substances

Avg: 45%

40%
patients receiving schedule three controlled substances

Avg: 36%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 23%

$71
Average prescription price

Avg: $117

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank